Identification of immune subtypes of cervical squamous cell carcinoma predicting prognosis and immunotherapy responses

BACKGROUND: The main limitation of current immune checkpoint inhibitors (ICIs) in the treatment of cervical cancer comes from the fact that it benefits only a minority of patients. The study aims to develop a classification system to identify immune subtypes of cervical squamous cell carcinoma (SCC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yimin, Lu, Shun, Wang, Shubin, Peng, Xinhao, Lang, Jinyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142504/
https://www.ncbi.nlm.nih.gov/pubmed/34030694
http://dx.doi.org/10.1186/s12967-021-02894-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142504/
https://www.ncbi.nlm.nih.gov/pubmed/34030694
http://dx.doi.org/10.1186/s12967-021-02894-3

Ejemplares similares